CGT-focused CDMOs are becoming essential partners in modern biomanufacturing by providing specialized infrastructure, regulatory expertise, and GMP-compliant processes. They enable biotech companies to overcome complex manufacturing challenges, accelerate clinical development, ensure product quality, and successfully commercialize advanced cell and gene therapies in an increasingly co... https://xelleratherapeutic.wixsite.com/xellera-therapeutics/post/why-cgt-focused-cdmos-are-the-future-of-biomanufacturing